Nearly one in seven people who give birth experience .
Right now, there鈥檚 only one PPD medication, called brexanolone, currently approved by the FDA. While it鈥檚 known to be extremely effective, .
But a revolution in treating perinatal and postpartum depression may be underway.
Earlier this summer, researchers published promising Phase 3 trial results of a new medication called .
From :
We talk with experts about the current landscape of treatment for perinatal and postpartum depression and what FDA approval of zuranolone could mean.
Copyright 2021
